• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

MJardin Group Announces Closing of GrowForce Acquisition To Create The Preeminent Global Cannabis Management Platform

Share:

December 10, 2018

MJardin Group, Inc., a leader in cannabis management, today announced the closing of its acquisition of GrowForce Holdings Inc., a vertically integrated international cannabis platform headquartered in Toronto and the release to the Company of the net proceeds of GrowForce’s July 2018 subscription receipt financing.

The transactions were completed after the closing of markets on November 30, 2018. After reflecting those subscription receipts that were redeemed as part of closing, GrowForce raised gross proceeds of $34.7 million of new equity in its July 2018 subscription receipt offering. In connection with the acquisition of GrowForce by the Company, approximately 30 million MJardin common shares were issued or will become issuable upon the exercise of certain previously issued GrowForce options and warrants.

“With the closing of this strategic transaction, MJardin is well positioned to continue to grow our global footprint of managed and owned facilities,” said Rishi Gautam, Chairman and Chief Executive Officer of MJardin Group. “MJardin now has one the largest international footprints of any cannabis provider and we intend to leverage our scale for continued growth both organically and through strategic acquisitions of cannabis assets in the U.S., Canada, Europe, Africa and Latin America.”

Advisors and Counsel

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Canaccord Genuity Corp. acted as the financial advisor to MJardin. Stikeman Elliott LLP acted as legal counsel to MJardin.

KES 7 Capital Inc. and Cormark Securities acted as the financial advisors to the board of directors of GrowForce, who also received an updated independent fairness opinion from GMP Securities. WeirFoulds LLP acted as legal counsel to GrowForce.

Date: December 10, 2018

Source: BusinessWire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Athersys, Inc. Announces Pricing of $3.5 Million Public OfferingAthersys, Inc. Announces Pricing of $3.5 Million Public Offering
  • Varex To Acquire Leading Linear Array Digital Detector Maker Direct ConversionVarex To Acquire Leading Linear Array Digital Detector Maker Direct Conversion
  • FDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 TreatmentsFDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 Treatments
  • Belgian university spinoff closes €1m seed financing roundBelgian university spinoff closes €1m seed financing round
  • Shore Capital-Backed IZI Medical Announces Acquisition of RadioMed Corporation, and its VISICOIL™ product family, from IBA S.A.Shore Capital-Backed IZI Medical Announces Acquisition of RadioMed Corporation, and its VISICOIL™ product family, from IBA S.A.
  • Education, Culture Key to Artificial Intelligence in HealthcareEducation, Culture Key to Artificial Intelligence in Healthcare
  • Picard Medical, Inc. Acquires Mechanical Heart Replacement TechnologyPicard Medical, Inc. Acquires Mechanical Heart Replacement Technology
  • Pharmaceutical Market Boosting the Growth Worldwide: Pharmaceutical Market Dynamics and Trends, Efficiencies Forecast 2026Pharmaceutical Market Boosting the Growth Worldwide: Pharmaceutical Market Dynamics and Trends, Efficiencies Forecast 2026

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications